Page last updated: 2024-09-04

olmesartan and iproniazid

olmesartan has been researched along with iproniazid in 2 studies

Compound Research Comparison

Studies
(olmesartan)
Trials
(olmesartan)
Recent Studies (post-2010)
(olmesartan)
Studies
(iproniazid)
Trials
(iproniazid)
Recent Studies (post-2010) (iproniazid)
8411855541,785882

Protein Interaction Comparison

ProteinTaxonomyolmesartan (IC50)iproniazid (IC50)
Cytochrome P450 3A4Homo sapiens (human)6.85
Cytochrome P450 2D6Homo sapiens (human)7.97
Amine oxidase [flavin-containing] BRattus norvegicus (Norway rat)7.5
Amine oxidase [flavin-containing] A Rattus norvegicus (Norway rat)5
Amine oxidase [flavin-containing] AHomo sapiens (human)5.7032
Amine oxidase [flavin-containing] BHomo sapiens (human)5.9633
C-X-C chemokine receptor type 3Homo sapiens (human)6.56
Sigma intracellular receptor 2Rattus norvegicus (Norway rat)7.5

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ekins, S; Williams, AJ; Xu, JJ1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY1

Other Studies

2 other study(ies) available for olmesartan and iproniazid

ArticleYear
A predictive ligand-based Bayesian model for human drug-induced liver injury.
    Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12

    Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands

2010
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
    Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10

    Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding

2012